Reaction

Colorectal Adenocarcinoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 221 reports · 2 co-occurring drugs

As of the last recalculation, Colorectal Adenocarcinoma appears in 221 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 110.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Panitumumab17110.6110.8
Trifluridine And Tipiracil435.735.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.